News Home

Do Analysts Agree Monday on Novartis AG (NVS) Stock's Target Price?

Monday, April 01, 2024 01:38 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Monday on Novartis AG (NVS) Stock's Target Price?

Wall Street is positive on Novartis AG (NVS). On average, analysts give the stock a Buy rating. The average price target is $117.8, which means analysts expect the stock to gain by 23.02% over the next twelve months. That average ranking earns the stock an Analyst Rating of 20, which is better than 20% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3.5
Wall Street analysts are rating NVS a Buy today. Find out what this means to you and get the rest of the rankings on NVS!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Novartis AG Stock Today?

Novartis AG (NVS) stock is trading at $95.76 as of 1:25 PM on Monday, Apr 1, a decline of -$1.01, or -1.04% from the previous closing price of $96.77. The stock has traded between $95.45 and $97.06 so far today. Volume today is light. So far 633,719 shares have traded compared to average volume of 1,497,285 shares. Click Here to get the full Stock Report for Novartis AG stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App